Skip to main content
. 2022 Jul 9;42(7):1379–1391. doi: 10.1007/s10875-022-01325-2

Fig. 3.

Fig. 3

Evaluation of SARS-CoV-2-specific humoral response and circulating CD4 + T cells in vaccinated and unvaccinated COVID-19 patients requiring hospitalization. Anti-N IgG (A), anti-S IgM (B), anti-S IgG (C), and neutralizing Ig (D) titers in vaccinated (blue dots) and unvaccinated (red dots) COVID-19 patients requiring hospitalization. (E–F) Representative plots and frequency of Spike-specific B cells in 30 vaccinated (blue dots) and 26 unvaccinated (red dots) COVID-19 patients and Spike-specific plasmablasts (G–H) in 22 vaccinated (blue dots) and 18 unvaccinated (red dots) COVID-19 patients requiring hospitalization. Representative plots and frequency of Spike-specific (IJ) and N/M-specific (K–L) CD4+ T cells defined by CD154+ expression and production of at least 1 cytokine among IL-2, IFN-γ, and TNF-α in 26 vaccinated (blue dots) and 22 unvaccinated (red dots) COVID-19 patients requiring hospitalization. Black lines indicate mean values. *P < 0.05; ***P < 0.001 calculated with Mann–Whitney U test